Suchergebnisse - "Alping, Peter"

PubPharm (16)

1

Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis : A Nationwide Cost-Effectiveness Study

enthalten in: Annals of neurology | 2024

von Alping, P. | Neovius, M. | Piehl, F. | +1

2

Disease-modifying therapies in multiple sclerosis : A focused review of rituximab

enthalten in: Basic & clinical pharmacology & toxicology | 2023

von Alping, P.

3

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes : Results from a population-based cohort study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Fink, K. | Gorczyca, A. | Alping, P. | +7

4

Disease‐modifying therapies in multiple sclerosis : A focused review of rituximab

enthalten in: Basic & Clinical Pharmacology & Toxicology | 2023

von Alping, P.

5

Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

enthalten in: Neurology | 2021

von Alping, P. | Burman, J. | Lycke, J. | +2

6

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

enthalten in: Annals of neurology | 2020

von Alping, P. | Askling, J. | Burman, J. | +13

7

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

enthalten in: JAMA neurology | 2020

von Luna, G. | Alping, P. | Burman, J. | +13

CommentIn: J Neurol. 2020 May;267(5):1567-1569. - PMID 32303837

8

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

enthalten in: Annals of Neurology | 2020

von Alping, P. | Askling, J. | Burman, J. | +13

9

Validation of the Swedish Multiple Sclerosis Register : Further Improving a Resource for Pharmacoepidemiologic Evaluations

enthalten in: Epidemiology (Cambridge, Mass.) | 2019

von Alping, P. | Piehl, F. | Langer-Gould, A. | +2

10

enthalten in: Annals of neurology | 2016

von Alping, P. | Frisell, T. | Svenningsson, A. | +1

CommentOn: Ann Neurol. 2016 Jun;79(6):950-8. - PMID 27038238